Supramox

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Supramox

What is Supramox?

Supramox is a prescription antibiotic medication used to treat a variety of bacterial infections. It belongs to the group of medicines known as penicillins, specifically the aminopenicillin class. It is designed to stop the growth of bacteria or eliminate them entirely by interfering with the formation of the bacterial cell wall.

Composition and Mechanism

The active ingredient in Supramox is amoxicillin. As a broad-spectrum antibiotic, it is effective against a wide range of Gram-positive and Gram-negative bacteria. When the medication is introduced into the body, it targets specific enzymes that bacteria need to build their protective outer layers. Without a stable cell wall, the bacteria cannot survive or multiply, allowing the body's immune system to clear the infection.

Common Uses

Supramox is utilized in clinical settings to manage infections located in various parts of the body. These typically include:

  • Respiratory Tract Infections: Such as pneumonia, bronchitis, and tonsillitis.
  • Ear, Nose, and Throat Infections: Including sinusitis and middle ear infections (otitis media).
  • Urinary Tract Infections: Affecting the bladder or kidneys.
  • Skin Infections: Bacterial imbalances affecting the skin and soft tissues.

Because it is an antibiotic, Supramox is only effective against infections caused by bacteria. It has no effect on viral infections, such as the common cold or the flu.

Regulatory References

  1. MedlinePlus - Amoxicillin
  2. Amoxicillin - European Medicines Agency
  3. Amoxicillin - StatPearls - NIH

What side effects are possible with Supramox?

Possible Side Effects and Safety Information

The safety profile of Supramox (Amoxicillin) is structured based on officially documented adverse reactions and regulatory safety classifications from government health authorities.

Frequency-Classified Adverse Reactions

Adverse reactions are classified by their documented frequency:

  • Common: Adverse events reported frequently include diarrhea, nausea, and skin rash.
  • Rare: Reactions occurring rarely include reversible changes in blood counts (leucopenia, thrombocytopenia), interstitial nephritis, and liver inflammation (hepatitis).

System-Organ Classes and Serious Reactions

The label documents effects across several body systems, including Gastrointestinal disorders, Skin and subcutaneous tissue disorders, Immune system disorders, and Hepatobiliary disorders.

Serious Adverse Reactions are rare but critically important and include:

  • Anaphylaxis and other severe hypersensitivity reactions.
  • Severe Cutaneous Adverse Reactions (SCAR), such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).
  • Clostridioides difficile-Associated Diarrhea (CDAD)/pseudomembranous colitis.

Safety Constraints and Considerations

Contraindications officially restrict the use of Supramox. The medicine must not be used by individuals with a history of serious hypersensitivity (allergic) reactions to Amoxicillin, any other penicillin, or a history of anaphylaxis to other beta-lactam antibiotics.

Population-Specific Notes: Patients with severe renal impairment (kidney disease) require a specific dosage adjustment, as directed in the regulatory labeling, to minimize the risk of drug accumulation and potential toxicity, such as convulsions. Additionally, the development of a skin rash is noted as being highly likely when the drug is used in patients with infectious mononucleosis.

Overdose and Emergency Response

Overdose and when to seek help

Overdosage with Supramox (Amoxicillin) is officially documented to involve a range of clinical manifestations, primarily affecting the gastrointestinal system and the central nervous system (CNS). Documented signs include acute nausea, vomiting, and diarrhea. CNS effects can encompass confusion, agitation, and hyperactivity, with reports of severe skin rash.

Severe or life-threatening outcomes are specifically linked to CNS depression and renal complications. Severe overdose carries a risk of convulsions or seizures, particularly in individuals with pre-existing impaired renal function. A critical, officially documented risk is amoxicillin crystalluria, the formation of crystals in the urine, which may progress to acute renal injury, especially following the ingestion of massive doses.

Immediate Emergency Action

In the event of suspected overdose, regulatory guidance mandates that you contact a poison control center or seek immediate medical attention from an emergency department. Urgent help must be sought if the affected individual has collapsed, had a seizure, or has trouble breathing. Management is strictly symptomatic and supportive, as no specific antidote is known. Officially described supportive measures focus on maintaining vital functions and ensuring adequate fluid intake to mitigate the risk of crystalluria and aid drug elimination. In severe cases, the procedural step of haemodialysis is documented for the effective removal of Amoxicillin from the circulation.

Therapeutic Uses of Supramox

What Supramox Treats: Main Uses and Benefits

Supramox (Amoxicillin) is generally used to help manage susceptible bacterial infections across multiple systems, providing supportive assistance to ease the overall symptom burden. The medication is applied across domains where additional symptomatic support is needed, including for infections of the ear, nose, throat, urinary tract, skin, and respiratory tract. This medication's therapeutic application is relevant in clinical settings for acute symptoms that interfere with daily functioning, providing support to help ease the overall symptom load.

This medication assists with managing symptom clusters that may become intense or disruptive. It provides support to manage acute discomfort, such as fever, localized pain, and symptoms related to systemic imbalance. It is commonly applied to address conditions presenting with acute or disruptive episodes, including infections of the ears, sinuses, throat, the lungs, the urinary tract, as well as dental abscesses and early-stage Lyme disease.

Quick Fact: Relief for Acute Discomfort
Common Symptom Axis: Symptoms related to inflammatory or irritative states.
Typical Benefit: Contributes to improved comfort during symptomatic periods, such as by easing symptoms related to inflammatory or irritative states like ear pain and painful urination.
Clinical Context: Relevant when short-term symptomatic assistance is needed, often as a first-line choice for common bacterial illnesses.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Supramox?

Regulatory authorities define eligibility for Supramox (Amoxicillin) based on a patient's medical history and physiological status.

Contraindications (Must Not Use)

Individuals who must not use Supramox are those with a history of a severe hypersensitivity reaction (such as anaphylaxis) to Amoxicillin or to any other beta-lactam antibiotic (e.g., penicillin or cephalosporin class drugs).

Restricted or Conditional Use

Eligibility is restricted for certain populations:

  • Infectious Mononucleosis: Supramox is not recommended for patients with confirmed or suspected infectious mononucleosis, as a high percentage may develop a non-allergic skin rash.
  • Severe Renal Impairment: Patients with severe kidney dysfunction require a conditional use status, as regulatory labels mandate a required adjustment to the standard regimen.
  • Infants and Children: The medication is approved for pediatric use. However, use in infants under three months is limited, and specific formulations (e.g., extended-release tablets) may have minimum age restrictions.
  • Pregnancy and Lactation: Use is generally permitted during pregnancy and breastfeeding, though labeling advises caution.

What should I know about interactions with other medicines?

Supramox (Amoxicillin) has documented interaction patterns with certain medicinal products and laboratory procedures, as defined in official regulatory documents.

The primary pharmacokinetic interaction involves Probenecid. This substance is documented to inhibit the renal tubular secretion of Amoxicillin, which results in increased and prolonged concentrations of the antibiotic in the bloodstream due to reduced clearance. In terms of pharmacodynamic effects, co-administration with Oral Anticoagulants may increase the prolongation of prothrombin time, a measure of blood clotting.

Separately, combining Amoxicillin with Allopurinol is officially associated with an increased risk of developing a skin rash. Other documented interactions include the potential for reduced efficacy of combined oral contraceptives and possible interference with the primary desired bactericidal effect when co-administered with certain bacteriostatic antibiotics, such as tetracyclines.

Regarding administration context, Amoxicillin can be taken without regard to meals, as food does not significantly alter its absorption, and there are no mandatory administration timing separation rules. Lastly, high urine concentrations of Amoxicillin may lead to false-positive results when using copper reduction methods for urinary glucose testing. Due to substantial renal excretion, the risk of toxic reactions may be greater for patients with impaired renal function.

Mechanism of Action

Irreversible Inhibition of Bacterial Cell Wall Cross-Linking

The primary action of Amoxicillin is to selectively target and irreversibly inhibit bacterial Penicillin-Binding Proteins (PBPs), which catalyze the cross-linking of peptidoglycan polymers. By covalently binding to these targets, the drug arrests the final step of peptidoglycan cross-linking. This action is directed solely against structures unique to bacterial cell wall synthesis.


The Bactericidal Cascade: From Target to Cell Lysis

The failure to properly construct the cell wall initiates a lethal mechanistic cascade. The structurally deficient bacterial cell is unable to counteract internal osmotic pressure, which, along with the activation of bacterial autolytic enzymes, leads to the rapid swelling and rupture (cell lysis) of the bacterium. The resulting physiological effect is the elimination of susceptible bacterial populations—a bactericidal outcome.


Limitations: Enzymatic and Target Resistance

The effectiveness of this mechanism is constrained by bacterial counter-mechanisms, predominantly the production of boldsymbolbeta-Lactamase enzymes. These enzymes deactivate Amoxicillin by hydrolyzing its beta-lactam ring, preventing the essential binding to PBPs. Additionally, genetic modification of the PBPs themselves can reduce the drug's binding affinity, functionally limiting the efficacy of the mechanism against resistant strains.

Dosage and Administration Information

How to Use Supramox

Supramox (Amoxicillin) is administered according to specific principles concerning its route, dose, frequency, and duration. The primary route of administration in outpatient settings is oral (by mouth), but the medication is also approved for intravenous (IV) or intramuscular (IM) injection when required clinically.

Standard Adult Dosing and Schedule

Dosing is based on the severity of the condition and is typically prescribed at consistent intervals to maintain appropriate drug levels. For general infections, the regimen is often prescribed as 500 mg every 12 hours (q12h) or 250 mg every 8 hours (q8h). For more severe or recurrent infections, higher doses, such as 875 mg q12h, are utilized.

Administration Context and Duration

Oral forms of Supramox can be taken with or without food as the presence of a meal does not significantly impair absorption. The overall duration of use is typically a fixed course ranging from 7 to 14 days. For infections caused by Streptococcus pyogenes, the treatment course is a minimum of 10 days.

Special Conditions: Dose adjustments are mandatory for patients with severe renal impairment (Glomerular Filtration Rate (GFR) less than 30 mL/min). In these cases, the 875 mg dose is not appropriate, and the total daily dose must be reduced to align with renal adjustment tables.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Supramox (Amoxicillin)

The available research evidence for Supramox has been examined by health authorities worldwide. The evidence base primarily consists of clinical evaluations, including large-scale randomized trials and systematic reviews, which explore Supramox's use as a subject of research for infections caused by susceptible bacteria. The information below describes the patterns observed in these studies, without making personal predictions.


Evidence for Use in Acute Respiratory Tract Infections

The evidence, as reported in regulatory summaries, largely comes from Randomized Controlled Trials (RCTs). These studies examine outcomes such as symptom change and bacteriological status for conditions like pneumonia and otitis media. Findings describe patterns observed in these trials, sometimes comparing measured outcomes to those of active control agents. A notable limitation is the difficulty in reliably distinguishing bacterial from viral causes in all study participants.


Evidence for Use in Genitourinary Tract Infections

Research on infections of the urinary tract has focused on prospective, controlled trials evaluating Clinical Cure Rates and Bacteriological Clearance Rates. Scientific literature consistently notes a limitation in that outcomes were evaluated only for infections caused by bacteria that lack resistance to this type of medicine. Researchers also explore the rate of infection relapse or recurrence over defined time intervals.


Evidence in Special Populations

Clinical studies have included a wide range of patients, notably pediatric patients (infants and older children) was studied for acute respiratory infections, as well as adults, sometimes stratified by disease severity. However, data for certain groups remain insufficient, and research is ongoing to fully characterize outcomes for all special populations and those with certain comorbidities.


What is Still Uncertain About Supramox

Key evidence gaps exist in the research landscape. A key limitation is that long-term effects are not fully established beyond the short post-treatment follow-up periods assessed in most trials. Evidence quality varies across studies, particularly older ones where poor reporting of adverse events was noted. Additionally, scientific literature indicates that research on infections caused by bacteria that have developed resistance to this class of antibiotics is highly restricted.

Key Studies & References

  1. Amoxicillin: MedlinePlus Drug Information (Authoritative Overview)
  2. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age
  3. Equivalency Of Oral Amoxicillin Vs Injectable Penicillin In Children With Severe Pneumonia (NCT00227331)

Frequently Asked Questions (FAQ)

Common questions about Supramox (FAQ)


Q: What are the most commonly reported side effects of Supramox?

According to official product information, the most commonly reported side effects of this medicine include diarrhea, nausea, and skin rash. Severe or unexpected reactions are typically noted in the official regulatory guidance, and any concerns are generally directed to a healthcare professional.


Q: Can Supramox cause stomach issues like diarrhea?

Yes, regulatory documents list gastrointestinal issues as common events. Specifically, diarrhea and nausea are included among the frequently reported side effects associated with the use of this medicine.


Q: Is it normal to feel a mild headache when taking Supramox?

Official product information classifies side effects by how frequently they are reported. While adverse events like headache may occur, they are generally not classified among the most common adverse reactions, such as diarrhea or nausea.


Q: Is Supramox effective against viral infections?

The medicine is not indicated for viral infections. Official documents confirm that Supramox (Amoxicillin) is classified as an antibacterial drug and is officially indicated only for the treatment of infections that are proven or strongly suspected to be caused by susceptible bacteria.


Q: What happens if I take Supramox and you don't need it?

Regulatory guidance emphasizes that the medicine should only be used for necessary bacterial infections. Limiting use to confirmed bacterial infections is described as an action to reduce the development of drug-resistant bacteria and maintain the medicine's effectiveness.


Q: Is there a generic version of Supramox available?

Yes. The active ingredient in the medicine is Amoxicillin. Amoxicillin is the name for the generic form of the medicine and is available internationally.


Q: Is it possible to develop a tolerance to Supramox?

In medical terms, what is often called 'tolerance' is known as bacterial resistance. Official documents describe that bacteria can develop mechanisms, such as producing certain enzymes, that prevent the drug from working, thus functionally limiting the medicine's effectiveness over time.


Q: How long does Supramox stay in your system?

Pharmacokinetic data in regulatory documents indicate that the medicine's half-life is approximately one hour. Most of the medicine is processed and leaves the body through the urine, and amounts of the drug can typically be detected for up to 8 hours after a dose.


Q: What is the difference between Supramox and Amoxicillin?

Supramox is a brand name used by the manufacturer to market the product. Amoxicillin is the internationally recognized name for the active chemical ingredient within the medicine.


Q: Does Supramox make you sleepy or drowsy?

Official drug safety documentation does not typically list drowsiness or sleepiness among the common or frequently reported side effects. Any unexpected changes are generally documented by healthcare professionals.


Q: Are there any common foods to avoid while taking Supramox?

The official product labeling states that the medicine can be taken with or without food, as the presence of a meal does not significantly alter its absorption. There are typically no specific common foods that are prohibited while using this medicine.


Q: Can Supramox interact with common pain relievers like ibuprofen?

Official interaction sections primarily detail interactions with medicines like Probenecid, oral anticoagulants, and allopurinol. Interactions with common non-prescription pain relievers such as ibuprofen are generally not listed in the core regulatory texts.


Q: Is it okay to drink coffee or caffeine while taking Supramox?

Official drug interaction summaries provided by regulatory bodies do not list caffeine or coffee as a substance with a documented pharmacological interaction pattern with this medicine.


Q: Can Supramox interact with herbal supplements?

Official product labeling often notes that interactions with herbal remedies or supplements may be unknown, as these products are not subject to the same testing requirements as prescription medicines. Full disclosure of all products, including supplements, is a standard practice noted in regulatory guidelines.


Q: How soon after stopping Supramox can I consume alcohol?

Official regulatory documents do not typically list alcohol as having a documented pharmacological interaction with this specific medicine. They do not specify a mandatory waiting period for consumption after stopping the drug.


Q: Is Supramox safe for older adults or seniors?

Clinical trials of the medicine have included elderly patients. Official labeling indicates that the selection of regimen should be cautious, and monitoring of kidney function is often considered, reflecting the general approach to prescribing for older adults, who are more likely to have decreased renal function.


Q: Are there different strengths or doses of Supramox available?

Yes, official regulatory documents list the availability of the medicine in multiple strengths and forms. These include capsules and tablets in various strengths (e.g., 250 mg, 500 mg, 875 mg) and different concentrations of oral suspension.


Q: Does Supramox cause any long-term health issues?

Official research summaries indicate that key evidence gaps exist in the research landscape. Specifically, they note that the long-term effects are not fully established beyond the short post-treatment follow-up periods assessed in most clinical trials.


Q: Does Supramox cause sensitivity to the sun?

Photosensitivity reactions (an increased sensitivity to the sun) are not listed as a common or frequently reported adverse reaction in the official product labeling for this medicine.


Q: Is Supramox known to interact with antacids?

Interactions are possible. Taking the medicine with some antacids that contain substances like aluminum or magnesium hydroxide may potentially reduce the absorption of the medicine, which could affect its effectiveness.


Q: Can I drive after taking Supramox?

Official safety documentation generally states that the medicine is not expected to affect the ability to drive or operate heavy machinery. However, the label notes that if rare side effects that may affect alertness (such as convulsions or dizziness) occur, this potential impact is generally addressed by a health professional.


Q: What is the purpose of the inactive ingredients in Supramox tablets?

Inactive ingredients are listed in the official description section and have no direct therapeutic effect. They are included in the formulation for purposes such as maintaining product stability, aiding in the manufacturing process, providing color, or helping the tablet disintegrate properly for absorption.


Q: What kind of studies led to the approval of Supramox?

The medicine was approved by regulatory bodies based on the review of data from clinical studies, including large-scale randomized trials. These studies primarily evaluated its effectiveness and safety profile in treating infections caused by susceptible bacteria. Initial U.S. approval for the active ingredient was in 1974.


Q: Are there any specific monitoring requirements while taking Supramox?

Specific monitoring requirements are usually restricted to patients with severe renal impairment (kidney disease). In these cases, the patient requires a specific dosage adjustment based on their kidney function to prevent the drug from accumulating in the body.

How should Supramox be stored and disposed of?

Storage Conditions

Dosage Form Temperature and Environment Stability and Handling
Capsules/Tablets Store at room temperature (68 F to 77 F), away from excess heat and moisture. Keep the container tightly closed and in its original packaging.
Oral Suspension Store in the refrigerator or at room temperature. Do not freeze the liquid formulation. The suspension must be shaken well before each use. Any unused portion must be discarded after 14 days of reconstitution.

All forms of this medication must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Supramox should be disposed of via a drug take-back program if one is available. If a program is not available, the FDA recommends mixing the medicine with an undesirable substance (such as used coffee grounds or dirt), placing the mixture into a sealable container, and throwing it in the household trash. Personal information on the prescription label should be scratched out before the container is discarded.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Supramox found in:

A-Z Index: